INTEGRAGEN News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.01.18	IntegraGen Launches SIRIUS™ and MERCURY™ - Big Data Tools Which Enable Ultra-Efficient Exploration of Large-Scale Genomic Data (Businesswire)
09.01.18	IntegraGen and GoPath Laboratories Sign Licensing Agreement for the Commercialization of miR-31-3p Test in North America (Businesswire)
30.10.17	IntegraGen Receives Galien MedStartUp Award for Their Collaboration with The Solution Lab on ICE Genomic Software Interpretation Tool (Businesswire)
09.10.17	IntegraGen Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic Colorectal Cancer (Businesswire)
09.01.17	IntegraGen Reports Sharp Increase in Sales During 2016 (Businesswire)
14.10.16	IntegraGen Reports Revenues for First Half of 2016 (Businesswire)
10.10.16	New Data on IntegraGen’s miR-31-3p Biomarker Featured in Presentation at 2016 ESMO Congress (Businesswire)
07.07.16	IntegraGen Reports Strong Revenue Growth During First Half of 2016 (Businesswire)
29.06.16	Greater Paris University Hospitals, AP-HP and IntegraGen Agree to a Research Partnership to Develop a Common Platform for High-Throughput Sequencing (Businesswire)
29.06.16	Greater Paris University Hospitals, AP-HP and IntegraGen Agree to a Research Partnership to Develop a Common Platform for High-Throughput Sequencing (Businesswire)
06.06.16	IntegraGen Presents Positive Data at 2016 ASCO Meeting on the Role of microRNA Biomarker miR-31-3p in Patients with Metastatic Colorectal Cancer Enrolled in FIRE-3 Clinical Trial (Businesswire)
02.12.15	IntegraGen Collaborating with FIRE-3 Clinical Trial Investigators to Study hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker (Businesswire)
02.12.15	IntegraGen Collaborating with FIRE-3 Clinical Trial Investigators to Study hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker (Businesswire)
01.06.15	IntegraGen Presents Results of Two Studies during 2015 ASCO Meeting with New Positive Data on the Role of microRNA Biomarker miR-31-3p in Patients with Metastatic Colorectal Cancer (Businesswire)
24.03.15	The Institut Pasteur Announces an Alliance with IntegraGen to Strengthen its High-Throughput Sequencing Activities in Microbiology (Businesswire)
05.02.15	IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test (Businesswire)
02.06.14	IntegraGen Presents Data at ASCO 2014 Annual Meeting on microRNA Biomarker Which Predicts Outcomes in Metastatic Colorectal Cancer Patients (Businesswire)
15.05.14	IntegraGen Announces Publication of Study with Biomarker Associated with Survival in Metastatic Colorectal Cancer Patients Treated with Drug Therapy (Businesswire)
03.04.14	IntegraGen Announces Collaborative Agreement with Pfizer to Evaluate IntegraGen’s Proprietary Hepatocellular Carcinoma Molecular Signature (Businesswire)
03.04.14	IntegraGen Announces Collaborative Agreement with Pfizer to Evaluate IntegraGen’s Proprietary Hepatocellular Carcinoma Molecular Signature (Businesswire)
24.03.14	IntegraGen and Gustave Roussy Announce the Set-up of a High-Throughput Clinical Sequencing Unit (Businesswire)
24.03.14	IntegraGen and Gustave Roussy Announce the Set-up of a High-Throughput Clinical Sequencing Unit (Businesswire)
21.02.14	IntegraGen Announces Publication of Study Which Supports the Association of Common Genetic Variants in the Development of Autism (Businesswire)
14.01.14	IntegraGen Collaborating with New EPOC Study Investigators to Validate Metastatic Colorectal Cancer Biomarker (Businesswire)
28.10.13	IntegraGen Announces Study Results with Advanced Version of the ARISk Test Designed to Identify Risk of Autism in Broader Patient Population (Businesswire)
23.10.13	IntegraGen Reports 1st Half Results for 2013 (Businesswire)
14.10.13	IntegraGen Obtains Exclusive License for MicroRNA Which Predicts Therapy Outcomes in Metastatic Colorectal Cancer (Businesswire)
08.07.13	IntegraGen Announces 18% Growth in Revenues in H1 2013 (Businesswire)
08.07.13	IntegraGen announces the Publication of the Results of an International Study with its 5-Gene Prognostic Molecular Signature for Hepatocellular Carcinoma Patients in Gastroenterology (Businesswire)
08.07.13	IntegraGen: 18% Growth in Revenues in H1 2013 (Businesswire)
23.04.12	IntegraGen – Annual Report 2011 (Businesswire)
17.04.12	IntegraGen, Inc. Names Michael Dresner, National Sales Director (Businesswire)
17.04.12	IntegraGen, Inc. Names Michael Dresner, National Sales Director (Businesswire)
04.04.12	IntegraGen Launches ARISk™ Test, a Genetic Screening Tool for Autism in High-Risk Children (Businesswire)
06.03.12	45% Growth of Genomic Services in 2011 – IntegraGen Becomes the First French Services Lab Equipped with an Illumina MiSeq (Businesswire)
06.03.12	IntegraGen Announces 45% Growth of Genomic Services in 2011 (Businesswire)
08.12.11	IntegraGen – Appointment of Laurence Riot Lamotte as Chief Financial Officer (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu INTEGRAGEN

Aktien Top/Flop

Meistgelesene Nachrichten